Countagen Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
Countagen General Information
Description
Developer of a consumable reagent kit intended to analyze gene editing efficiency and specificity with high precision and in an affordable way. The company offers reliable counts and identifies gene edits with accuracy using basic laboratory equipment, enabling healthcare providers to accelerate gene-editing research and save money.
Contact Information
Website
www.countagen.comCorporate Office
- Nobels väg 16
- Stockholm
- 171 65 Solna
- Sweden
Corporate Office
- Nobels väg 16
- Stockholm
- 171 65 Solna
- Sweden
Countagen Timeline
Countagen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | 17-Apr-2024 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 01-Jan-2024 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 27-Jun-2022 | $1.15M | $1.34M | Completed | Generating Revenue | |
| 1. Seed Round | 01-Jan-2021 | $193K | $193K | Completed | Startup |
Countagen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 4,483 | $35.17 | $35.17 | 1x | $35.17 | 6.56% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Countagen Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Countagen Patents
Countagen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202418533-D0 | Methods | Pending | 17-Dec-2024 | ||
| GB-2704627-A | Methods | Pending | 17-Dec-2024 | ||
| WO-2026131879-A1 | Methods for detecting incorrectly-edited polynucleotide sequence | Pending | 17-Dec-2024 | ||
| EP-4423293-B1 | Method | Active | 25-Oct-2022 | ||
| AU-2022379387-A1 | Method | Inactive | 25-Oct-2021 | C12Q1/6806 |
Countagen Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Countagen Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DRIVE (KI Innovations Business Incubator) | Accelerator/Incubator | |||
| Almi Invest | Venture Capital | Minority |
Countagen FAQs
-
When was Countagen founded?
Countagen was founded in 2020.
-
Where is Countagen headquartered?
Countagen is headquartered in Solna, Sweden.
-
What is the size of Countagen?
Countagen has 6 total employees.
-
What industry is Countagen in?
Countagen’s primary industry is Biotechnology.
-
Is Countagen a private or public company?
Countagen is a Private company.
-
What is Countagen’s current revenue?
The current revenue for Countagen is .
-
How much funding has Countagen raised over time?
Countagen has raised $2.87M.
-
Who are Countagen’s investors?
DRIVE (KI Innovations Business Incubator) and Almi Invest have invested in Countagen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
